<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Oyaksungisan, the herbal prescription composed of eleven herbs, has been widely used in treatment of cerebral <z:mpath ids='MPATH_124'>infarct</z:mpath> in Oriental Medicine </plain></SENT>
<SENT sid="1" pm="."><plain>However, the mechanisms by which the herbal formula affects on the production of pro- and anti-inflammatory cytokines in <z:e sem="disease" ids="C0007785" disease_type="Disease or Syndrome" abbrv="">cerebral infarction</z:e> patients remain unknown yet </plain></SENT>
<SENT sid="2" pm="."><plain>The secretory levels of pro-inflammatory cytokines, including <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> <z:mp ids='MP_0001651'>necrosis</z:mp> factor (TNF)-alpha, interleukin (IL)-1beta, and IL-6, and IL-10 were significantly increased in both LPS and PHA-stimulated peripheral blood mononuclear cells (PBMCs) from <z:e sem="disease" ids="C0007785" disease_type="Disease or Syndrome" abbrv="">cerebral infarction</z:e> patients </plain></SENT>
<SENT sid="3" pm="."><plain>However, pretreatment with oyaksungisan significantly inhibited the secretion of pro- and anti-inflammatory in PBMCs </plain></SENT>
<SENT sid="4" pm="."><plain>Also, oyaksungisan induced a significant increase of transforming growth factor (TGF)-beta1 in PBMCs </plain></SENT>
<SENT sid="5" pm="."><plain>Thus, these data indicate that oyaksungisan may be beneficial in the cessation of inflammatory processes of cerebral <z:mpath ids='MPATH_124'>infarct</z:mpath> through suppression of TNF-alpha, IL-1beta, IL-6, and IL-10 and induction of TGF-beta1 </plain></SENT>
</text></document>